jagomart
digital resources
picture1_Supportive Psychotherapy Pdf 109695 | 1471 244x 7 58


 184x       Filetype PDF       File size 0.56 MB       Source: research.rug.nl


File: Supportive Psychotherapy Pdf 109695 | 1471 244x 7 58
university of groningen cognitive behavioral therapy versus short psychodynamic supportive psychotherapy in the outpatient treatment of depression driessen ellen van henricus l schoevers robert a cuijpers pim van aalst gerda ...

icon picture PDF Filetype PDF | Posted on 28 Sep 2022 | 3 years ago
Partial capture of text on file.
                                                                        
        University of Groningen
        Cognitive Behavioral Therapy versus Short Psychodynamic Supportive Psychotherapy in the
        outpatient treatment of depression
        Driessen, Ellen; Van, Henricus L.; Schoevers, Robert A.; Cuijpers, Pim; van Aalst, Gerda;
        Don, Frank J.; Hendriksen, Marielle; Kool, Simone; Molenaar, Pieter J.; Peen, Jaap
        Published in:
        BMC Psychiatry
        DOI:
        10.1186/1471-244X-7-58
        IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
        it. Please check the document version below.
        Document Version
        Publisher's PDF, also known as Version of record
        Publication date:
        2007
        Link to publication in University of Groningen/UMCG research database
           Citation for published version (APA):
           Driessen, E., Van, H. L., Schoevers, R. A., Cuijpers, P., van Aalst, G., Don, F. J., Hendriksen, M., Kool, S.,
           Molenaar, P. J., Peen, J., & Dekker, J. J. M. (2007). Cognitive Behavioral Therapy versus Short
           Psychodynamic Supportive Psychotherapy in the outpatient treatment of depression: a randomized
           controlled trial. BMC Psychiatry, 7, [58]. https://doi.org/10.1186/1471-244X-7-58
        Copyright
        Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
        author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
        The publication may also be distributed here under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license.
        More information can be found on the University of Groningen website: https://www.rug.nl/library/open-access/self-archiving-pure/taverne-
        amendment.
        Take-down policy
        If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
        and investigate your claim.
      
        Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
        number of authors shown on this cover page is limited to 10 maximum.
                 BMC Psychiatry                                                                                                                           BioMed Central
                 Study protocol                                                                                                                         Open Access
                 Cognitive Behavioral Therapy versus Short Psychodynamic 
                 Supportive Psychotherapy in the outpatient treatment of 
                 depression: a randomized controlled trial
                                                1,2                                 1                                         1                             2
                 Ellen Driessen*                    , Henricus L Van , Robert A Schoevers , Pim Cuijpers , 
                                                1                           1                                           1                             1
                 Gerdavan Aalst , Frank J Don , Mariëlle Hendriksen , Simone Kool , 
                                                   1                      1,2                                         1,2
                 Pieter J Molenaar , Jaap Peen                                 and Jack JM Dekker
                           1
                 Address:  Depression Research Group, JellinekMentrum Mental Health Care, Overschiestraat 65, 1062 XD Amsterdam, The Netherlands and 
                 2Department of Clinical Psychology, VU University Amsterdam, Van der Boechorststraat 1, 1081 BT Amsterdam, The Netherlands
                 Email: Ellen Driessen* - e.driessen@psy.vu.nl; Henricus L Van - rien.van@mentrum.nl; Robert A Schoevers - robert.schoevers@mentrum.nl; 
                 PimCuijpers- p.cuijpers@psy.vu.nl; Gerda van Aalst - gerda.van.aalst@mentrum.nl; Frank J Don - frank.don@mentrum.nl; 
                 Mariëlle Hendriksen - marielle.hendriksen@mentrum.nl; Simone Kool - simone.kool@mentrum.nl; 
                 Pieter J Molenaar - pieter.molenaar@mentrum.nl; Jaap Peen - jaap.peen@mentrum.nl; Jack JM Dekker - jack.dekker@mentrum.nl
                 * Corresponding author    
                 Published: 26 October 2007                                                   Received: 27 July 2007
                 BMC Psychiatry 2007, 7:58   doi:10.1186/1471-244X-7-58                       Accepted: 26 October 2007
                 This article is available from: http://www.biomedcentral.com/1471-244X/7/58
                 © 2007 Driessen et al; licensee BioMed Central Ltd. 
                 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
                 which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
                                  Abstract
                                  Background: Previous research has shown that Short Psychodynamic Supportive Psychotherapy
                                  (SPSP) is an effective alternative to pharmacotherapy and combined treatment (SPSP and
                                  pharmacotherapy) in the treatment of depressed outpatients. The question remains, however, how
                                  Short Psychodynamic Supportive Psychotherapy compares with other established psychotherapy
                                  methods. The present study compares Short Psychodynamic Supportive Psychotherapy to the
                                  evidence-based Cognitive Behavioral Therapy in terms of acceptability, feasibility, and efficacy in the
                                  outpatient treatment of depression. Moreover, this study aims to identify clinical predictors that
                                  can distinguish patients who may benefit from either of these treatments in particular. This article
                                  outlines the study protocol. The results of the study, which is being currently carried out, will be
                                  presented as soon as they are available.
                                  Methods/Design: Adult outpatients with a main diagnosis of major depressive disorder or
                                  depressive disorder not otherwise specified according to DSM-IV criteria and mild to severe
                                  depressive symptoms (Hamilton Depression Rating Scale score ≥ 14) are randomly allocated to Short
                                  Psychodynamic Supportive Psychotherapy or Cognitive Behavioral Therapy. Both treatments are
                                  individual psychotherapies consisting of 16 sessions within 22 weeks. Assessments take place at
                                  baseline (week 0), during the treatment period (week 5 and 10) and at treatment termination
                                  (week 22). In addition, a follow-up assessment takes place one year after treatment start (week 52).
                                  Primary outcome measures are the number of patients refusing treatment (acceptability); the
                                  number of patients terminating treatment prematurely (feasibility); and the severity of depressive
                                  symptoms (efficacy) according to an independent rater, the clinician and the patient. Secondary
                                  outcome measures include general psychopathology, general psychotherapy outcome, pain, health-
                                  related quality of life, and cost-effectiveness. Clinical predictors of treatment outcome include
                                                                                                                                                         Page 1 of 14
                                                                                                                                   (page number not for citation purposes)
               BMC Psychiatry 2007, 7:58                                                       http://www.biomedcentral.com/1471-244X/7/58
                             demographic variables, psychiatric symptoms, cognitive and psychological patient characteristics
                             and the quality of the therapeutic relationship.
                             Discussion: This study evaluates Short Psychodynamic Supportive Psychotherapy as a treatment
                             for depressed outpatients by comparing it to the established evidence-based treatment Cognitive
                             Behavioral Therapy. Specific strengths of this study include its strong external validity and the
                             clinical relevance of its research aims. Limitations of the study are discussed.
                             Trial registration: Current Controlled Trails ISRCTN31263312
               Background                                                        Short Psychodynamic Supportive Psychotherapy [5,6]
               Depressive disorders constitute a major health problem in         was developed in the early 90's as a structured psychody-
               today's world. According to the World Health Organiza-            namically orientated treatment for depressed outpatients
               tion, in the year 2000 depressive disorders were the lead-        within JellinekMentrum Mental Health Care Amsterdam
               ing cause of disability around the world and the fourth           (JMHC). Since then the acceptability, feasibility, and effi-
               leading contributor to the global burden of disease. It is        cacy of this treatment have been compared to pharmaco-
               estimated that by the year 2020 depression will comprise          therapy and combined treatment (SPSP and
               the world's second largest disease burden, second only to         pharmacotherapy) in four randomized clinical trials [7-
               ischemic heart disease [1]. Currently, more than 150 mil-         10]. In these studies, treatment acceptability is conceptu-
               lion people around the world are suffering from a depres-         alized by the number of patients refusing treatment when
               sion [2]. Consequently, there is a high need for effective        allocated to it by study randomization. Feasibility is the
               treatment.                                                        number of patients who terminate treatment prematurely.
                                                                                 Efficacy refers to the number of patients recovered from
               The efficacy of existing psychotherapies for depressive dis-      depressive symptoms according to an independent
               orders was recently reviewed by Roth & Fonagy [3]. They           observer, the patient and the therapist.
               conclude that in general psychotherapy is an effective
               treatment of depression when compared to placebo. Cog-            De Maat et al. [11] performed a 'mega-analysis' on the
               nitive Behavioral Therapy (CBT), Interpersonal Psycho-            data of the first three trials, in which the effects of SPSP,
               therapy (IPT), Problem Solving Therapy (PST), couple              pharmacotherapy, and combined treatment were com-
               therapy, bibliotherapy, and computer-aided therapy all            pared both in terms of symptom reduction and quality of
               have shown to be effective treatment methods, consist-            life improvement. The results suggest that the combina-
               ently efficacious in around 50–60% of cases. In contrast,         tion of SPSP and pharmacotherapy is more efficacious
               there still is limited evidence base for brief dynamic ther-      than pharmacotherapy alone. Besides patients finding
               apy, although this form of treatment is widely applied in         combined therapy more efficacious in reducing depressive
               clinical practice. According to Roth & Fonagy, the results        symptoms, no difference in efficacy was found when com-
               of the few available studies on brief dynamic therapy are         paring SPSP and combined therapy. SPSP and pharmaco-
               flawed by methodological problems and a probable bias             therapy were found to be equally efficacious, except for
               due to investigator alliance. The outcomes of good-quality        some indications that patients and therapists favor SPSP
               trials, they conclude, suggest effectiveness equal to the         with regard to symptom reduction. The results of the
               psychotherapies mentioned above, but the conclusions              above-mentioned trials further indicate a better accepta-
               that can be drawn about this treatment method are                 bility of SPSP compared to both pharmacotherapy and
               severely limited by the paucity of trials. This view is shared    combined treatment [8,10]; fewer patients refuse SPSP
               by the Cochrane reviewers of short-term psychodynamic             because there is no medication involved. With regard to
               therapies for common mental disorders [4]. They find              the feasibility, no differences were found [11].
               modest to moderate gains of brief dynamic therapy for a
               variety of patients, but also conclude that these findings        In sum, previous research suggests that, while the combi-
               should be interpreted with caution because of limited             nation of SPSP and pharmacotherapy seems to work bet-
               data. Due to the scarcity of studies, the authors cannot          ter than pharmacotherapy alone, the superiority of
               draw any conclusions about the efficacy for depressed             combined treatment to SPSP is less obvious. In addition,
               patients specifically. The present study aims at contribut-       SPSP and pharmacotherapy seem to be equally effica-
               ing to the gap in knowledge on this subject by comparing          cious. Furthermore, the trial results provide support for
               Short Psychodynamic Supportive Psychotherapy (SPSP)               the acceptability and feasibility of SPSP as an alternative
               and Cognitive Behavioral Therapy in the treatment of              treatment for depressed outpatients. Although combined
               depressed outpatients.                                            treatment appears to be more efficacious than SPSP alone,
                                                                                                                                  Page 2 of 14
                                                                                                                (page number not for citation purposes)
              BMC Psychiatry 2007, 7:58                                                     http://www.biomedcentral.com/1471-244X/7/58
              this form of treatment is less well accepted by patients         thermore, it is thought that patients showing a higher
              because of the required medication. Therefore SPSP might         degree of dysfunctional attitudes or cognitive reactivity to
              be a treatment of first choice for a great deal of depressed     sad mood might respond better to CBT, because CBT spe-
              outpatients.                                                     cifically attends to these cognitive aspects.
              As mentioned earlier, so far SPSP has been compared to           Methods/Design
              either pharmacotherapy or combined treatment. How-               Design
              ever, the question remains how SPSP compares with                This study is a randomized controlled trial comparing the
              another established form of psychotherapy. Therefore the         acceptability, feasibility, and efficacy of Short Psychody-
              present study seeks to compare the acceptability, feasibil-      namic Supportive Psychotherapy (SPSP) and Cognitive
              ity, and efficacy of SPSP to CBT, which is an evidence-          Behavioral Therapy (CBT) in the treatment of depression.
              based psychotherapy for the treatment of depressive dis-         Participants are randomly allocated to either the SPSP or
              orders [3]. In addition, it is unclear whether there are spe-    CBT treatment condition. Participants receive pharmaco-
              cific groups of patients, who might benefit from one of          therapy in addition to their psychotherapy if they show
              these treatments in particular. This study aims to gain          severe depressive symptoms at baseline assessment (Ham-
              more insight into this issue as well.                            ilton Depression Rating Scale [14,15]; HDRS score > 24).
                                                                               The main outcome measure is the number of patients
              Research aims                                                    with depressive symptoms in remission (HDRS score ≤ 8)
              The aim of this study is twofold. First, the research com-       at the termination of psychotherapy at week 22. In case of
              pares Short Psychodynamic Supportive Psychotherapy               remaining depressive symptomatology at the termination
              and Cognitive Behavioral Therapy in terms of acceptabil-         of psychotherapy treatment (HDRS score ≥ 12 at week 22)
              ity, feasibility, and efficacy. Second, it seeks to identify     patients will receive care as usual according to the Jellinek-
              clinical predictors that distinguish patients that can bene-     Mentrum Mental Health Care regular procedures. This
              fit from either of these treatments in particular. These clin-   usually consists of additional pharmacotherapy as
              ical predictors include demographic variables,                   described in more detail later.
              (comorbid) psychiatric symptoms, cognitive and psycho-
              logical patient characteristics, and the quality of the ther-    Participants/Setting
              apeutic alliance.                                                Participants are adult outpatients referred to one of three
                                                                               JellinekMentrum Mental Health Care (JMHC) clinics by
              Hypotheses                                                       their general practitioner on account of psychiatric com-
              Considering the first research aim, it is hypothesized that      plaints. These three mental health clinics are located in
              both treatments will be equally efficacious. This is based       the city centre, the northern part, and the western part of
              on Roth and Fonagy's [3] conclusions described above. In         Amsterdam (the Netherlands). It is therefore assumed
              line with the earlier trials, it is further hypothesized that    that these clinics attend to a heterogeneous group of
              both psychotherapies will be equally acceptable and feasi-       inhabitants.
              ble to patients as well, since neither includes the use of
              medication.                                                      Inclusion criteria are a main diagnosis of major depressive
                                                                               disorder or depressive disorder not otherwise specified
              With regard to the second aim, it is expected that a predic-     (NOS), with or without a dysthymic disorder, according
              tive relationship will be found between patient character-       to DSM-IV criteria [16], mild to severe depressive symp-
              istics and the efficacy of one of the two treatments in          toms (HDRS score ≥ 14 at base line), age between 18 and
              particular. Because systematic research on other predictive      65 years, and written informed consent.
              patient characteristics is relatively scarce, only three
              hypotheses are formulated. Though based on a small               Exclusion criteria are the presence of psychotic symptoms
              dataset, Van et al. [12] found that a subgroup of patients       or a bipolar disorder, use of antidepressants, risk of sui-
              with comorbid symptoms of anxiety benefited less from            cide or loss of impulse control, substance misuse or abuse
              SPSP. It is hypothesized that CBT will be more effective for     within the last six months (use of hard drugs, use of can-
              this group of patients, because CBT is generally consid-         nabis more than three times a week or alcohol above 21
              ered to be the treatment of choice for anxiety disorders. In     units a week), use of antipsychotics or mood stabilizers,
              addition, it is hypothesized that patients with comorbid         use of benzodiazepines (equivalent to more than 30 mg
              personality disorders may benefit more from SPSP. While          oxazepam per week), and use of medication that influ-
              these patients are usually regarded as difficult to treat,       ences mental functions. Patients are also excluded from
              SPSP showed positive treatment effects when combined             the trial if they are pregnant, not able to fill in the ques-
              with pharmacotherapy in a subgroup of depressed                  tionnaires because of language problems or physical diffi-
              patients with comorbid personality pathology [13]. Fur-          culties, absent for more than three weeks during the
                                                                                                                              Page 3 of 14
                                                                                                            (page number not for citation purposes)
The words contained in this file might help you see if this file matches what you are looking for:

...University of groningen cognitive behavioral therapy versus short psychodynamic supportive psychotherapy in the outpatient treatment depression driessen ellen van henricus l schoevers robert a cuijpers pim aalst gerda don frank j hendriksen marielle kool simone molenaar pieter peen jaap published bmc psychiatry doi x important note you are advised to consult publisher s version pdf if wish cite from it please check document below also known as record publication date link umcg research database citation for apa e h r p g f m dekker randomized controlled trial https org copyright other than strictly personal use is not permitted download or forward distribute text part without consent author and holder unless work under an open content license like creative commons may be distributed here terms article fa dutch act indicated by taverne more information can found on website www rug nl library access self archiving pure amendment take down policy believe that this breaches contact us prov...

no reviews yet
Please Login to review.